rs12272669 — UNKNOWN

An Uncharted B12 Locus on Chromosome 11

Vitamin B12 (cobalamin) levels in circulation are controlled by a cascade of transport, absorption, and processing steps — each influenced by genetic variation at multiple points. From gut absorption (FUT2) to cellular delivery (TCN2) to intracellular activation (MMACHC), genome-wide association studies have now mapped over a dozen loci influencing serum B12.

The rs12272669 variant sits on chromosome 11 at position 71,681,563 (GRCh38), in a non-coding intergenic region near the pseudogene ALG1L9P. Despite its location in a functionally sparse region of the genome, a large sequencing-based GWAS identified the A allele as significantly associated with higher circulating vitamin B12 concentrations. What makes this locus unusual is the gap between its statistical significance and its mechanistic explanation: no protein-coding gene at this position has an obvious connection to cobalamin metabolism.

The Evidence

The association was discovered in the Grarup et al. 2013 GWAS¹¹ Grarup et al. 2013 GWAS
Genetic Architecture of Vitamin B12 and Folate Levels Uncovered Applying Deeply Sequenced Large Datasets. PLoS Genet. 2013;9(6):e1003530, which analyzed ~22.9 million sequence variants across up to 45,576 Icelandic and Danish individuals. The study identified six novel B12 loci and confirmed seven previously known associations. At rs12272669, the A allele was associated with higher serum B12 (p = 3.0 × 10⁻⁹) with a beta coefficient of +0.51 on the quantile-normalized scale — a substantial effect size that reached genome-wide significance. The signal was detected in the Icelandic cohort (n=37,283 with B12 measurements), where the A allele had a minor allele frequency of only 0.22%.

The frequency discrepancy between the Icelandic cohort (0.22%) and global population databases (~9–18% depending on ancestry group) is notable. Modern population data from gnomAD and 1000 Genomes show the A allele at roughly 9–11% in European, East Asian, and African populations and 18% in South Asians. The extreme rarity in Iceland suggests either a population-specific frequency difference, or that the rsid has undergone reassignment in dbSNP between the 2013 study and current databases — a known issue with older GWAS rsid cataloging.

The mechanism connecting chromosome 11q13.4 to circulating B12 is not established. Possibilities include cis-regulatory effects on a nearby expressed transcript that influences B12 transport or storage, tagging of a causal variant elsewhere through linkage disequilibrium, or an artifact of imputation in the original study. The evidence level is therefore classified as emerging — the association reached statistical significance in a large well-powered study, but without replication or mechanistic characterization.

For context, well-characterized B12 loci already in the GeneOps database illustrate what a biologically understood signal looks like. FUT2 (rs601338) affects B12 absorption by controlling mucin fucosylation in the intestinal epithelium. TCN2 (rs1801198) controls how efficiently B12 is delivered to cells via holotranscobalamin. FUT6 (rs78060698) alters haptocorrin-bound B12 levels through fucosylation. Each of these has a clear pathway connection. The chromosome 11 locus at rs12272669 lacks this mechanistic anchor.

What the A Allele Does

The A allele is the less common variant in most populations and the one associated with higher serum B12. Because the effect direction is toward higher B12 (not lower), the G allele — the reference and most common allele globally — is associated with typical or baseline B12 levels by comparison.

For individuals with the GG genotype, B12 levels are typical for the population; the genetic contribution from this locus is neutral. Carriers of the A allele (AG or AA) may have modestly higher circulating B12 on average, which likely confers a slight buffer against functional B12 insufficiency.

Practical Context

This locus does not yet meet the threshold for targeted clinical action — the mechanism is unknown, replication in independent cohorts has not been published, and the effect size, while statistically significant, is modest in absolute terms. The primary value of documenting it here is completeness within the B12- pathway genetic map and transparency about what is and is not known.

B12 status overall is best assessed by measuring holotranscobalamin (holoTC, the "active B12" fraction) or methylmalonic acid (MMA), regardless of any single variant. These functional markers reflect actual cofactor availability at the cellular level and are informative regardless of which B12-pathway variants you carry.

Interactions

This variant exists in the context of a well-mapped genetic pathway. The established B12 loci — FUT2 absorption, FUT6 haptocorrin binding, TCN2 delivery — combine additively with rare and common variants across the B12 pathway. If you carry risk variants in TCN2 (GG genotype at rs1801198) or are a FUT2 non-secretor (AA at rs601338), the chromosome 11 A allele may partially offset those risks by nudging B12 levels slightly upward, but no compound genotype data exists for this specific combination.